Muutke küpsiste eelistusi

E-raamat: Occupational Exposures: Chemical Carcinogens and Mutagens [Taylor & Francis e-raamat]

(Oregon State University, USA), (Lawrence Livermore National Laboratory (LLNL), USA)
Teised raamatud teemal:
  • Taylor & Francis e-raamat
  • Hind: 166,18 €*
  • * hind, mis tagab piiramatu üheaegsete kasutajate arvuga ligipääsu piiramatuks ajaks
  • Tavahind: 237,40 €
  • Säästad 30%
Occupational Exposures: Chemical Carcinogens and MutagensSuurem pilt
Teised raamatud teemal:
Taylor & Francis e-raamatudRohkem infot Taylor & Francis e-raamatute kohta
Raamatu kodulehekülg: https://www.taylorfrancis.com/books/9781003220114
Occupational Exposures: Chemical Carcinogens and Mutagens offers a focused emphasis on chemical exposures associated with carcinogenic and mutagenic impacts along with associated controls for mitigating and controlling exposures. It discusses a range of topics including hematopoietic system impact, reproductive system impact, inorganic compounds, halogenated compounds, carbamates, polycyclic aromatic hydrocarbons, aromatic amines, product elimination and substation, exposure control methods, and human biological impact.





Presents a comprehensive account of carcinogens and mutagens for occupational and environmental health professionals Covers preventive measures and controls for carcinogens and mutagens Discusses exposure controls, exposure pathways, impacts, and treatments

The book is ideal for professionals and graduate students in the fields of occupational health and safety, industrial engineering, and chemical engineering.
Authors xi
1 Polycyclic aromatic hydrocarbons
1(14)
1.1 Introduction
1(5)
1.1.1 Benzene
4(2)
1.2 Exposure pathways
6(1)
1.2.1 Inhalation exposures and impact
6(1)
1.2.2 Dermal exposures and impact
7(1)
1.2.3 Ingestion exposure and impact
7(1)
1.3 Chemical to human interface
7(1)
1.4 Exposure control methods
8(2)
1.4.1 Product elimination and substation
9(1)
1.4.2 Engineering controls
9(1)
1.4.3 Administrative controls
9(1)
1.4.4 Protective equipment and effectiveness
9(1)
1.5 Human biological impact
10(2)
1.5.1 Potential impact to exposed individual
11(1)
1.5.2 Potential impact to off springs
11(1)
1.6 Treatment of resultant illness
12(1)
References
12(3)
2 Aromatic amines
15(18)
2.1 Introduction
15(3)
2.2 Heterocyclic aromatic amines
18(1)
2.3 Exposure pathways
18(5)
2.3.1 Inhalation exposures and impact
20(2)
2.3.2 Dermal exposures and impact
22(1)
2.3.3 Ingestion exposure and impact
23(1)
2.4 Chemical to human interface
23(2)
2.5 Exposure control methods
25(2)
2.5.1 Product elimination and substation
25(1)
2.5.2 Engineering controls
26(1)
2.5.3 Administrative controls
26(1)
2.5.4 Protective equipment and effectiveness
26(1)
2.6 Human biological impact
27(1)
2.6.1 Potential impact to offsprings
27(1)
2.7 Treatment of resultant illness
28(2)
References
30(3)
3 Nitrosamines
33(14)
3.1 Introduction
33(4)
3.2 Exposure pathways
37(1)
3.2.1 Inhalation exposure and impact
37(1)
3.2.2 Dermal exposure and impact
37(1)
3.2.3 Ingestion exposure and impact
37(1)
3.3 Chemical to human interface
38(1)
3.4 Exposure control methods
38(1)
3.4.1 Product elimination and substitution
39(1)
3.5 Administrative controls
39(1)
3.6 Personal protective equipment
39(1)
3.7 Human biological impact
40(3)
3.7.1 Potential impact on exposed individual
40(3)
3.7.2 Potential impact to off-spring
43(1)
3.8 Treatment of resultant illness
43(1)
References
44(3)
4 Azo dyes
47(14)
4.1 Introduction
47(7)
4.1.1 Azo dye production
53(1)
4.2 Chemical to human interface
54(1)
4.3 Exposure pathways
55(2)
4.3.1 Inhalation exposures and impact
56(1)
4.3.2 Dermal exposures and impact
56(1)
4.3.3 Ingestion exposure and impact
57(1)
4.4 Exposure control methods
57(2)
4.4.1 Product elimination and substitution
58(1)
4.4.2 Engineering, controls
58(1)
4.4.3 Administrative controls
58(1)
4.4.4 Protective equipment and effectiveness
58(1)
4.5 Human biological impact
59(1)
4.6 Treatment of resultant illness
59(1)
References
60(1)
5 Carbamates
61(14)
5.1 Introduction
61(1)
5.1.1 Carbamate used as therapeutics
62(1)
5.2 Exposure pathways
62(2)
5.2.1 Inhalation exposures and impact
63(1)
5.2.2 Dermal exposures and impact
64(1)
5.3 Exposure control methods
64(2)
5.3.1 Product elimination and substation
65(1)
5.3.2 Engineering controls
65(1)
5.3.3 Administrative controls
65(1)
5.3.4 Protective equipment and effectiveness
66(1)
5.4 Human biological impact
66(2)
5.4.1 Potential impact on exposed individual
66(1)
5.4.2 Potential impact on off-spring
67(1)
5.5 Treatment of resultant illness
68(5)
Decontamination
68(1)
Respiratory
69(1)
Atropine
69(1)
Oxime
70(1)
Benzodiazepines
70(1)
Disposition
70(3)
5.6 Technical information
73(1)
References
74(1)
6 Halogenated compounds
75(18)
6.1 Introduction
75(1)
6.2 Halogenated hydrocarbons
76(1)
6.3 Halogenated organic compounds
77(2)
6.4 Halogenated solvents
79(3)
6.5 Exposure pathways
82(2)
6.5.1 Inhalation exposures and impact
82(1)
6.5.2 Dermal exposures and impact
82(1)
6.5.3 Ingestion exposure and impact
83(1)
6.6 Chemical to human interface
84(1)
6.7 Exposure control method
84(4)
6.7.1 Product elimination and substation
85(1)
6.7.2 Engineering controls
85(2)
6.7.3 Administrative controls
87(1)
6.7.4 Protective equipment and effectiveness
88(1)
6.8 Human biological impact
88(2)
6.8.1 Potential impact to exposed individual
88(1)
6.8.2 Potential impact on offspring
89(1)
6.9 Treatment of resultant illness
90(1)
References
90(3)
7 Inorganic compounds
93(26)
7.1 Introduction
93(7)
7.2 Exposure pathways
100(7)
7.2.1 Inhalation exposures and impact
102(1)
7.2.2 Dermal exposure impact
102(5)
7.2.3 Ingestion exposure and impact
107(1)
7.3 Chemical to human interface
107(1)
7.4 Exposure control methods
108(3)
7.4.1 Product elimination and substation
108(1)
7.4.2 Engineering controls
109(2)
7.4.3 Administrative controls
111(1)
7.4.4 Protective equipment and effectiveness
111(1)
7.5 Human biological impact
111(5)
7.5.1 Potential impact on exposed individual
114(1)
7.5.2 Potential impact on offspring
115(1)
7.6 Treatment of resultant illness
116(1)
References
116(3)
8 Chemical carcinogens
119(14)
8.1 Introduction
119(8)
8.1.1 Mechanism of cancer formation
120(1)
8.1.2 Common carcinogens
121(1)
8.1.2.1 Asbestos
121(1)
8.1.2.2 Benzene
121(3)
8.1.2.3 Hexavalent chromium
124(1)
8.1.2.4 Formaldehyde
125(1)
8.1.2.5 Silica
125(1)
8.1.2.6 Vinyl chloride
125(1)
8.1.2.7 IARC
126(1)
8.1.2.8 ACGIH
126(1)
8.1.2.9 NTP
126(1)
8.2 Exposure pathways
127(2)
8.2.1 Inhalation exposures and impact
128(1)
8.2.2 Dermal exposures and impact
128(1)
8.2.3 Ingestion exposure and impact
129(1)
8.3 Exposure control methods
129(2)
8.3.1 Engineering controls
129(1)
8.3.2 Administrative controls
130(1)
8.3.3 Protective equipment and effectiveness
130(1)
8.4 Potential impact on exposed individual
131(1)
8.5 Potential impact on offspring
132(1)
8.6 Treatment of resultant illness
132(1)
References
132(1)
9 Mutagens
133(10)
9.1 Introduction
133(1)
9.2 Classification of mutagens
134(1)
9.3 Factors affecting actions of mutagens
135(1)
9.4 Common types of mutagens
135(3)
9.4.1 Base analogues
135(1)
9.4.2 Intercalating agents
136(1)
9.4.3 Metal ions
137(1)
9.4.4 Alkylating agents
138(1)
9.5 Exposure "pathways
138(2)
9.5.1 Inhalation exposures and impact
139(1)
9.5.2 Dermal exposures and impact
139(1)
9.6 Exposure control methods
140(2)
9.6.1 Elimination of hazards
140(1)
9.6.2 Engineering controls
140(1)
9.6.3 Administrative controls
141(1)
9.6.4 Personal protective equipment and effectiveness
141(1)
9.6.4.1 Dermal protective PPE
141(1)
9.6.4.2 Respiratory protection
141(1)
9.7 Treatment of resultant illness
142(1)
References
142(1)
10 Chemical agents and occupational-related diseases
143(14)
10.1 Introduction
143(1)
10.2 Occupational diseases from chemical exposures
143(1)
10.3 Prevention of occupational-related diseases resulting from chemicals
144(10)
10.3.1 Occupational cancers
146(1)
10.3.2 Occupational skin diseases
147(5)
10.3.3 Occupational respiratory disease
152(2)
References
154(3)
Appendix A Exposure and risk assessment strategy 157(6)
Appendix B Exposure monitoring 163(6)
Appendix C Personal protective equipment 169(12)
Appendix D Medical surveillance 181(12)
Index 193
Püsilink: https://www.kriso.ee/db/9781003220114_pe.html
Märksõnad: